medicine Product List and Ranking from 5 Manufacturers, Suppliers and Companies

Last Updated： Aggregation Period:Oct 15, 2025～Nov 11, 2025
This ranking is based on the number of page views on our site.

medicine Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Oct 15, 2025～Nov 11, 2025
This ranking is based on the number of page views on our site.

  1. 日本工機 高機能品営業部 Tokyo//Building materials, supplies and fixtures manufacturers
  2. null/null
  3. マーケットリサーチセンター Tokyo//Service Industry
  4. null/null
  5. 5 エクシィズ Gifu//Building materials, supplies and fixtures manufacturers
Go to Company Ranking

medicine Product ranking

Last Updated： Aggregation Period:Oct 15, 2025～Nov 11, 2025
This ranking is based on the number of page views on our site.

  1. Non-explosive, low-vibration steam pressure crushing agent 'Gunsizer' 日本工機 高機能品営業部
  2. Tohoku Univ. Technology： PPARα agonists that improve cognitive function：T22-091
  3. Market Research Report on New COVID-19 Treatment Drugs Worldwide マーケットリサーチセンター
  4. Science of Ceramics 3: Pursuing Beauty in Glazes
  5. 4 Tile glaze: production, types, differences *Technical materials available エクシィズ

medicine Product List

31～39 item / All 39 items

Displayed results
World Pet Cancer Treatment Market Research Report (2023-2028)

World Pet Cancer Treatment Market Research Report (2023-2028)

Global Market for Pet Cancer Treatment (2023-2028): Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy, Others

According to the market research report by Mordor Intelligence, the global pet cancer treatment market size, which was $364.07 million at the end of the fiscal year, is projected to rise at an average annual rate of 8.8% during the forecast period, reaching $589.03 million in five years. This report extensively investigates and analyzes the global market for pet cancer treatment, including an introduction, research methodology, executive summary, market trends, analysis by treatment type (chemotherapy, radiation therapy, immunotherapy, targeted therapy, and others), analysis by animal type (dogs, cats, and others), regional analysis (United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, Middle East, South Africa, Brazil, Argentina), competitive landscape, market opportunities, and future trends.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
World Urinary Tract Infection (UTI) Market Research Report (up to 2027)

World Urinary Tract Infection (UTI) Market Research Report (up to 2027)

Global Urinary Tract Infection (UTI) Market (up to 2027): By Disease, By Treatment Method, By End User, By Region

360iResearch predicts that the global market size for urinary tract infections (UTI), which was $10.25 billion in 2021, will reach $10.93 billion in 2022 and expand to $15.23 billion by 2027, growing at a CAGR of 6.81%. This research report provides a multifaceted analysis of the global UTI market, including sections on introduction, research methodology, executive summary, market overview, market insights, disease-specific analysis (cystitis, pyelonephritis, urethritis), treatment method analysis (diagnosis, treatment), end-user analysis (hospitals, self-management), regional analysis (North America, United States, Canada, Brazil, Asia-Pacific, Japan, China, India, South Korea, Taiwan, Europe/Middle East/Africa, United Kingdom, Germany, France, Russia, others), competitive landscape, and company information.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
World Antitumor Drug Market Research Report (～2027)

World Antitumor Drug Market Research Report (～2027)

Global Antitumor Drug Market (up to 2027): By Disease, By Route of Administration, By Drug, By Drug Classification, By End User, By Distribution Channel, By Region

360iResearch predicts that the global market size for antitumor drugs, which was $27.8 billion in 2021, will reach $31.13 billion in 2022 and expand to $55.3 billion by 2027, growing at a CAGR of 12.14%. This research report analyzes the global market for antitumor drugs from multiple perspectives, including an introduction, research methodology, executive summary, market overview, market insights, disease-specific analysis (breast cancer, leukemia, lung cancer, melanoma, prostate cancer), route of administration analysis (intramuscular, intraperitoneal, intravenous, intraventricular/intrathecal, intravesical), drug class analysis (alkylating agents, antimetabolites, antitumor antibiotics, mitotic inhibitors, topoisomerase inhibitors), end-user analysis (clinics, hospitals, specialty centers), regional analysis (North and South America, United States, Canada, Brazil, Asia-Pacific, Japan, China, India, South Korea, Taiwan, Europe/Middle East/Africa, United Kingdom, Germany, France, Russia, others), competitive landscape, and company information.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
World Thrombolytic Drug Market Research Report (～2027)

World Thrombolytic Drug Market Research Report (～2027)

Global Thrombolytic Drug Market (up to 2027): By Type, By Category, By Distribution Channel, By Region

360iResearch predicts that the global thrombolytic drug market, which was valued at $891.34 million in 2021, will reach $1,043.49 million in 2022 and expand to $2,324.80 million by 2027, growing at a CAGR of 17.32%. This research report provides a multifaceted analysis of the global thrombolytic drug market, including sections on introduction, research methodology, executive summary, market overview, market insights, analysis by type (fibrin-specific agents, non-fibrin-specific agents), analysis by category (urokinase, alteplase, reteplase, streptokinase, t-PA), analysis by distribution channel (e-pharmacies, hospital pharmacies, retail pharmacies), regional analysis (North America, United States, Canada, Brazil, Asia-Pacific, Japan, China, India, South Korea, Taiwan, Europe/Middle East/Africa, United Kingdom, Germany, France, Russia, and others), competitive landscape, and company information.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Global Monoclonal Antibody Treatment Market Research Report (up to 2027)

Global Monoclonal Antibody Treatment Market Research Report (up to 2027)

Global Monoclonal Antibody Therapy Market (up to 2027): By Source, By End User, By Application, By Region

360iResearch predicts that the global monoclonal antibody therapy market size, which was $125.84 billion in 2021, will reach $141.33 billion in 2022 and expand to $254.96 billion by 2027, growing at a CAGR of 12.48%. This research report analyzes the global market for monoclonal antibody therapy from multiple perspectives, including an introduction, research methodology, executive summary, market overview, market insights, analysis by source (chimeric monoclonal antibodies, human monoclonal antibodies, humanized monoclonal antibodies), analysis by end-user (hospitals, individual clinics, research institutions), analysis by application (autoimmune diseases, cancer, blood disorders, infectious diseases, ophthalmic disorders), regional analysis (North and South America, United States, Canada, Brazil, Asia-Pacific, Japan, China, India, South Korea, Taiwan, Europe/Middle East/Africa, United Kingdom, Germany, France, Russia, and others), competitive landscape, and company information.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Market Research Report on Small Cell Lung Cancer (SCLC) Treatment Drugs Worldwide

Market Research Report on Small Cell Lung Cancer (SCLC) Treatment Drugs Worldwide

World Market for Small Cell Lung Cancer (SCLC) Treatments (2022-2031): Chemotherapy, Targeted Therapy, Immunotherapy, and Others

The research report by Transparency Market Research analyzes the global market for small cell lung cancer (SCLC) treatment drugs and clarifies the market situation. This document includes an introduction, assumptions & research methodology, executive summary, market overview, key insights, analysis by type of treatment (chemotherapy, targeted therapy, immunotherapy, and others), analysis by end-user (hospitals, cancer treatment centers, and others), regional analysis (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), and competitive landscape.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Market Research Report on New COVID-19 Treatment Drugs Worldwide

Market Research Report on New COVID-19 Treatment Drugs Worldwide

Global Market for COVID-19 Treatment Drugs (2022-2031): Corticosteroids, Antivirals, Monoclonal Antibodies

The research report by Transparency Market Research analyzes the global market for COVID-19 treatment drugs and clarifies the market situation. This document includes an introduction, assumptions & research methodology, executive summary, market overview, key insights, analysis by drug class (corticosteroids, antiviral agents, monoclonal antibodies, kinase inhibitors, and others), analysis by route of administration (oral, non-oral), analysis by distribution channel (hospital pharmacies, retail pharmacies, online pharmacies), regional analysis (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), and competitive landscape, among other topics.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
World Thyroid Cancer Treatment Drug Market Research Report (～2027)

World Thyroid Cancer Treatment Drug Market Research Report (～2027)

Global Market for Thyroid Cancer Treatment Drugs (up to 2027): Cabozantinib-S-Malate, Caprelsa, Cometriq, Doxorubicin Hydrochloride

According to the research report by 360iResearch, the global market size for thyroid cancer treatment drugs, which was $562.82 million in 2021, is expected to grow to $620.63 million in 2022 and further expand at an average annual rate of 10.44%, reaching $1,021.64 million by 2027. This report provides a multifaceted investigation into the global market for thyroid cancer treatment drugs, including an introduction, research methodology, executive summary, market overview, market insights, analysis by drug type (Cabozantinib - S - Malate, Caprelsa, Cometriq, Doxorubicin Hydrochloride, Ipilimumab), analysis by end-user (hospitals, oncology clinics, research institutions), regional analysis (North and South America, United States, Canada, Brazil, Asia-Pacific, Japan, China, India, South Korea, Taiwan, Europe/Middle East/Africa, United Kingdom, Germany, France, Russia, and others), competitive landscape, company information, and more.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
World Barganciclovir Market Research Report 2022-2031

World Barganciclovir Market Research Report 2022-2031

Global Market for Valganciclovir 2022-2031: Industry Analysis, Size, Share, Growth, Trends, Forecast

According to the research report by Transparency Market Research, the global valganciclovir market size, which was $288.6 million in 2022, is projected to reach $484.1 million by 2031, with an average annual growth rate of 4.6% during the forecast period. This report provides a comprehensive analysis of the global valganciclovir market, including an introduction, assumptions and research methodology, executive summary, market overview, market outlook, analysis by patient age (adult patients, pediatric patients), analysis by application (organ transplantation, cytomegalovirus retinitis), analysis by distribution channel (hospital pharmacies, retail pharmacies), regional analysis (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), and competitive landscape.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine

COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.